<DOC>
	<DOCNO>NCT00087984</DOCNO>
	<brief_summary>The purpose trial examine safety , feasibility , immunological response , clinical antitumor activity administer dendritic cell vaccine patient metastatic renal cell carcinoma .</brief_summary>
	<brief_title>RNA-Loaded Dendritic Cell Cancer Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Have new diagnosis metastatic renal cell carcinoma ; Must least 18 year old ; Have schedule unilateral nephrectomy ; ECOG 0 1 ; Free brain metastasis CT MRI ; Normal renal function contralateral kidney ; Male nonpregnant/nonlactating female appropriate birth control method study ; Clinically acceptable screening result . No immunosuppressive therapy limited corticosteroid ( include topical steroid steroid contain inhaler ) , azathioprine cyclosporine two month prior study entry ; No active autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Kidney cancer</keyword>
	<keyword>Renal cancer</keyword>
</DOC>